Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Mattman

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Clinical Chemistry|December 17, 2020
Method Limitations in LC-MS/MS and Immunonephelometric Measurement of IgG SubclassesGrace van der Gugten, Andre Mattman, Gordon Ritchie, et al.
BMC Public Health|May 10, 2012
Investigating maternal risk factors as potential targets of intervention to reduce socioeconomic inequality in small for gestational age: a population-based studyIrene Hayward, Lorraine Halinka Malcoe, Lesley A Cleathero, et al.
Scientific Reports|January 31, 2024
Mass spectrometry in IgG4-related disease diagnosisDaniel C Onwuka, Luke Y C Chen, Shing H Zhan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 10, 2020
Clinical utility of serum IgG4 measurementJulia L Varghese, Angela W S Fung, Andre Mattman, et al.
Molecular Genetics and Metabolism|September 27, 2005
Neonatal hyperphenylalaninemia, perinatal hemochromatosis, and renal tubulopathy: a unique patient or a novel metabolic disorder?Paula J Waters, Minesh Khashu, Yolanda Lillquist, et al.
Clinical Biochemistry|February 23, 2020
Null<sub>Canada</sub>: A novel α<sub>1</sub>-antitrypsin allele with in cis variants Glu366Lys and Ile100AsnSharon Chen, Mari L DeMarco, Mathew P Estey, et al.
Molecular Genetics and Metabolism|June 13, 2006
A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathyScot C Leary, Andre Mattman, Timothy Wai, et al.
Orphanet Journal of Rare Diseases|January 11, 2022
Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutationAndre Mattman, Elizabeth Nadeau, Michelle M Mezei, et al.
Blood|July 20, 2002
Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutationAndre Mattman, David Huntsman, Gillian Lockitch, et al.
Mitochondrion|April 3, 2020
Self-initiated lifestyle interventions lead to potential insight into an effective, alternative, non-surgical therapy for mitochondrial disease associated multiple symmetric lipomatosisElizabeth Nadeau, Michelle M Mezei, Mark Cresswell, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Clinical Chemistry|December 17, 2020
Method Limitations in LC-MS/MS and Immunonephelometric Measurement of IgG SubclassesGrace van der Gugten, Andre Mattman, Gordon Ritchie, et al.
BMC Public Health|May 10, 2012
Investigating maternal risk factors as potential targets of intervention to reduce socioeconomic inequality in small for gestational age: a population-based studyIrene Hayward, Lorraine Halinka Malcoe, Lesley A Cleathero, et al.
Scientific Reports|January 31, 2024
Mass spectrometry in IgG4-related disease diagnosisDaniel C Onwuka, Luke Y C Chen, Shing H Zhan, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 10, 2020
Clinical utility of serum IgG4 measurementJulia L Varghese, Angela W S Fung, Andre Mattman, et al.
Molecular Genetics and Metabolism|September 27, 2005
Neonatal hyperphenylalaninemia, perinatal hemochromatosis, and renal tubulopathy: a unique patient or a novel metabolic disorder?Paula J Waters, Minesh Khashu, Yolanda Lillquist, et al.
Clinical Biochemistry|February 23, 2020
Null<sub>Canada</sub>: A novel α<sub>1</sub>-antitrypsin allele with in cis variants Glu366Lys and Ile100AsnSharon Chen, Mari L DeMarco, Mathew P Estey, et al.
Molecular Genetics and Metabolism|June 13, 2006
A hemizygous SCO2 mutation in an early onset rapidly progressive, fatal cardiomyopathyScot C Leary, Andre Mattman, Timothy Wai, et al.
Orphanet Journal of Rare Diseases|January 11, 2022
Ketogenic diet for mitochondrial disease: potential role in treating the Multiple Symmetric Lipomatosis phenotype associated with the common MT-TK genetic mutationAndre Mattman, Elizabeth Nadeau, Michelle M Mezei, et al.
Blood|July 20, 2002
Transferrin receptor 2 (TfR2) and HFE mutational analysis in non-C282Y iron overload: identification of a novel TfR2 mutationAndre Mattman, David Huntsman, Gillian Lockitch, et al.
Mitochondrion|April 3, 2020
Self-initiated lifestyle interventions lead to potential insight into an effective, alternative, non-surgical therapy for mitochondrial disease associated multiple symmetric lipomatosisElizabeth Nadeau, Michelle M Mezei, Mark Cresswell, et al.
Pageof 11